Cumberland Pharmaceuticals Inc.CPIXNASDAQ
Loading
| Metric | Dec 21 | Dec 22 | Dec 23 |
|---|---|---|---|
| Revenue | 36 | 42 | 40 |
| Gross Profit | 27 | 33 | 33 |
| Operating Income | -8 | -6 | -10 |
| Net Income | -4 | -6 | -6 |
| EBITDA | -1 | 0 | 2 |
| EPS Diluted | -0.24 | -0.38 | -0.44 |
| Metric | Dec 21 | Dec 22 | Dec 23 |
|---|---|---|---|
| Cash & Equivalents | 27 | 20 | 18 |
| Total Current Assets | 46 | 46 | 36 |
| Total Assets | 84 | 93 | 82 |
| Total Current Liabilities | 19 | 29 | 28 |
| Total Liabilities | 42 | 57 | 53 |
| Total Equity | 43 | 36 | 30 |
| Total Debt | 16 | 21 | 18 |
| Net Debt | -11 | 1 | 0 |
| Metric | Dec 21 | Dec 22 | Dec 23 |
|---|---|---|---|
| Operating Cash Flow | 6 | 8 | 6 |
| Capital Expenditure | -0 | -2 | -0 |
| Free Cash Flow | 6 | 6 | 6 |
| Stock-Based Comp | 1 | 0 | 0 |
| Net Change in Cash | 2 | -7 | -1 |